Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. LifeWatch AG
  6. News
  7. Summary
    LIFE   CH0012815459

LIFEWATCH AG

(LIFE)
SummaryNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

LifeWatch AG : LifeWatch V: State-of-the-Art Smartphone with Healthcare Capabilities Empowering Patients and Consumers

06/27/2012 | 08:20am EDT

LifeWatch AG (SIX Swiss Exchange: LIFE), the leading wireless cardiac monitoring service and home sleep test provider in the U.S., presents today LifeWatch V, the world's first-of-its-kind healthcare smartphone. The fully featured state-of-the-art smartphone allows patients as well as health- and wellbeing-conscious consumers to self-operate a wide range of highly valuable embedded medical sensors, wellness-related applications, cloud-based services and 24/7 call center support.

As a next step of its product and geographical diversification LifeWatch presents today LifeWatch V, the world's first fully featured smartphone which operates on an android OS. The state-of-the-art solution offers multiple sophisticated embedded medical miniature sensors, wellness-related applications, cloud-based services and 24/7 call center support. By using the barely visible sensors on the phone's frame, patients as well as health- and wellbeing conscious consumers can track, capture, collect and analyze their health and medical measurements anywhere anytime. The features include ECG, body temperature, blood glucose, heart rate, blood oxygen saturation, body fat percentage and stress levels (heart rate variability). All collected data can be retrieved from the cloud for a follow-up anytime anywhere. Users can thus take corrective action, plan their diets and activities, securely share the information with a health provider or family member, trend and analyze the data and more. Patients are also able to program the unit to remind them of their drug type, dose and intake time.

LifeWatch V with add-on service offering

LifeWatch V was designed with a flexible service-product ecosystem in mind, allowing easy integration of services. The LifeWatch V handset unit includes a service enablement platform to support the transmission of medical data to be analyzed, evaluated and communicated to health professionals and call center personnel around the clock. The device wirelessly interacts with a cloud-based environment allowing users direct access to a wide range of valuable complementary medical and wellness related services.

Strategic alliances with local partners

Smartphones are positioned to overtake many computing functions that were reserved to computers alone. More importantly, the smartphone has emerged as an intimate device consumers carry with them anywhere and anytime, making it an ideal vehicle to let users self-test their health, especially users with an interest in the medical field. Recent market developments have witnessed the emergence of health-dedicated cellular phones.

Based on a full and complete Go-to-Market analysis LifeWatch intends to launch the healthcare solution smartphone world-wide. In the initial markets LifeWatch has identified several local partners to enter into strategic partnerships.

LifeWatch V: Medical specifications

EKG (1-Lead)

 

EKG dynamic range 0.15-5 mV.

Frequency response 0.5-40 Hz.

Sampling 12 bit, 250 samples /sec.

Test time: Average of 35 sec.

Heart rate  

HF measurement range 30 to 250 bpm

QRS detection sensitivity > 98%

QRS detection predictability > 98%

Result time: Average of 10 sec.

SpO2  

Method: Reflective R & IR emission

Oxygen saturation range: 70 to 100%

Accuracy: Standard deviation ± 1 digits

Test time: Average of 20 sec.

Glucose  

Range: 10-650 mg/dl

Sample size: 0,4-0,7 ?L

Accuracy: ± 10 mg/dL for glucose level < 75 mg/dL

12.5% for glucose level => 75 mg/dL

Test time: 3-5 sec.

IR-Thermometer   Range: 34 to 41 C°; Accuracy: ± 0,2 C°
Body fat percentage   Method: Bioelectrical Impedance
Operating temperature   10 to 40 C° (40 to 104 °F)
 
LifeWatch V: Technical specifications
Network   3G 850/1900/2100; 2G 850/900/1800/1900; 3G (HSDPA, 7.2 Mbps)
Operating system   Android 2.3 (Gingerbread)
Processor   Qualcomm MSM7227Turbo
Weight and dimensions (HxWxD)   162g; 132(mm) x 70.8(mm) x 13.2(mm)
Display   LCD 4.3" 480*480 Pixels (WVGA)
Battery capacity-   1500 mAh
Camera   5MP main camera + 300KP front camera
Connectivity  

Bluetooth Ver. 2.1 with BT/Wi-Fi-coexistence

Wi-Fi IEEE 802.11b/g/n

Memory   1GB Flash, 512MB RAM, T-Flash, Micro SD Slot (up to 32GB)
Certification   CE- Mark pending
Features   GPS, A-GPS supported

Don't miss it: Join us for a live presentation of LifeWatch V today:

Live demonstration: June 27, 2012, 3:30 p.m., Zurich, Metropol, Fraumünsterstrasse 12

Live Video Webcast in the IR section on www.lifewatch.com

Product website: http://www.lifewatchv.com/demo/

About LifeWatch AG

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products. LifeWatch is also introducing a new program for Home Sleep Testing of Obstructive Sleep Apnea (OSA) patients under the brand name NiteWatch. For additional information, please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/

Sensus Investor and Public Relations GmbH, Zürich:
Andreas Duffé, +41 433665511
Fax: +41 43 366 55 12
lifewatch@sensus.ch


ę Business Wire 2012
All news about LIFEWATCH AG
2017LIFEWATCH AG : Cancellation of all remaining publicly held registered shares of LifeWatch ..
EQ
2017LIFEWATCH AG : LifeWatch delisting from SIX Swiss Exchange approved
EQ
2017LIFEWATCH AG : LifeWatch applies for delisting
EQ
2017LIFEWATCH AG : Exemption from Publicity Obligations under Listing Requirements
EQ
2017LIFEWATCH : Five-year Corporate Integrity Agreement Success - Fully Completed
PR
2016LIFEWATCH AG : RIGHTS ISSUE: 10 new shares @ 9 CHF for 27 existing shares
FA
2016LIFEWATCH : Discloses Supplemental Information on Highmark Arbitration Case
PR
2016LIFEWATCH : TM) Appoints Andrew Moore as Chief Financial Officer
PR
2016LIFEWATCH : TM) Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service
PR
2016LIFEWATCH : Receives FDA Clearance for its Mobile Cardiac Telemetry 1-Lead Patch
PR
More news
Managers and Directors
Joseph H. Capper Chairman-Management Board
Christoph Heinzen Chief Operations Officer & CTO
Sector and Competitors
1st jan.Capi. (M$)
LIFEWATCH AG0.00%0
SARTORIUS AG88.12%51 509
BIOTAGE AB (PUBL)83.31%1 924
REVENIO GROUP OYJ15.61%1 813
CELLAVISION AB (PUBL)43.32%1 215
VAREX IMAGING CORPORATION63.97%1 079